We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UCG:MILUniCredit S.p.A. Analysis

Data as of 2026-07-30 - not real-time

€81.70

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

UniCredit is trading at €81.7, just above its 20‑day SMA of €81.6 and comfortably above the 50‑day SMA of €77.9, signalling a short‑term bullish bias. The price sits near a technical support zone at €78.9 and faces resistance around €83.9, while the RSI at 54 suggests neither overbought nor oversold conditions. Fundamentally, the bank appears undervalued with a trailing PE of ~11.4 versus an industry average of ~18, and a P/B of 1.81, offering a margin of safety. Despite a 7.8% dip in revenue, UniCredit maintains a robust operating margin of 62% and a profit margin of 44%, delivering a solid ROE of ~15.8% and a dividend yield near 4% with a modest payout ratio of 44%, indicating dividend sustainability. The MACD histogram is negative, hinting at potential near‑term weakness, but the overall trend remains bullish, supported by increasing volume and a low beta (~0.63) that points to defensive characteristics. Given the current valuation gap, strong cash generation, and defensive risk profile, the stock presents an attractive entry point for investors seeking income and value upside.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Price above 20‑day and 50‑day SMAs indicating bullish momentum
  • Technical support at €78.9 and upside potential toward €83.9
  • Strong dividend yield with sustainable payout

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued valuation relative to peers (PE ~11 vs industry ~18)
  • Forward EPS growth and improving earnings outlook
  • Attractive dividend yield combined with solid ROE

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Stable, defensive beta and low currency exposure
  • Consistent profitability and high dividend sustainability
  • Exposure to diversified European markets balancing growth and risk

Key Metrics & Analysis

Financial Health

Revenue Growth-7.80%
Profit Margin43.82%
P/E Ratio11.4
ROE15.78%
ROA1.23%
P/B Ratio1.8
Industry P/E18.1

Technical Analysis

TrendBullish
RSI54.4
Support€78.86
Resistance€83.88
MA 20€81.57
MA 50€77.95
MA 200€70.33
MACDBearish
VolumeIncreasing
Fear & Greed Index89.7

Valuation

Target Price€90.71
Upside/Downside11.03%
GradeUndervalued
TypeValue
Dividend Yield3.95%

Risk Assessment

Beta0.63
Volatility29.32%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.